Clara Bueno

9PUBLICATIONS
110CO-AUTHORS
Haematological tumoursEpigenetics (incl. genome methylation and epigenomics)Medical molecular engineering of nucleic acids and proteinsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 25, 2026
NG2-ITGA4 axis regulates Rho GTPases and leukemic aggressiveness in KMT2A-r B-ALL and is targetable with natalizumab.

|Apr 10, 2025
An unbiased genomewide screen uncovers 7 genes that drive hematopoietic stem cell fate from mouse embryonic stem cells.

Luis G Palma, Gayathri M Kartha, Maria Maqueda

|Mar 16, 2025
A TIM-3-Fc decoy secreted by engineered T cells improves CD19 CAR T-cell therapy in B-cell acute lymphoblastic leukemia.

Aïda Falgàs, Rodrigo Lázaro-Gorines, Samanta Romina Zanetti

|Aug 02, 2024
NG2 is a target gene of MLL-AF4 and underlies glucocorticoid resistance in MLLr B-ALL by regulating NR3C1 expression.

Belén Lopez-Millan, Alba Rubio-Gayarre, Meritxell Vinyoles

|Feb 14, 2024
Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo.

Laura Díez-Alonso, Aïda Falgas, Javier Arroyo-Ródenas

|Sep 27, 2023
A human genome editing-based MLL::AF4 ALL model recapitulates key cellular and molecular leukemogenic features.

Clara Bueno, Raul Torres-Ruiz, Talia Velasco-Hernandez

Pageof 2

Frequent Collaborators

4 joint publications

Meritxell Vinyoles

3 joint publications

Alba Martinez-Moreno

3 joint publications

Mercedes Guerrero-Murillo

3 joint publications

Ronald W W Stam